Previous Close | 41.06 |
1-Year Change | -15.32% |
6-Months Change | -25.71% |
3-Months Change | -12.1% |
Moving Avg (50d) | 42.919 |
Moving Avg (200d) | 51.183 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 2.24B |
Beta (3-Years) | 1.11 |
Revenue Growth (ttm) | -24.55% |
Net Profit Margin (ttm) | -4.51% |
Return On Assets (ttm) | -1.7% |
EPS (ttm) | -1.37 |
PE Ratio (ttm) | -29.97 |
Dividend Yield | % |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Industrials |
Industry: | Industrial Machinery |
Country: | United States |
Enovis is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world. Wikipedia